Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104753) titled 'Assessment of a bone breakdown marker in gum disease patients with Stage 1 high blood pressure' on Feb. 25.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Investigator Blinded

Primary Sponsor: Dr Amol Ranjan

Intervention: Intervention1: Scaling and root planing: Scaling and root planing and measurement of crevicular levels of N-Telopeptide with periodontitis at baseline, 1 month, 3 month and 6 months Control In...